Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Multianalyte SARS-CoV-2, Flu Test Gets CE Mark

NEW YORK – PerkinElmer announced on Monday its test for detecting and differentiating SARS-CoV-2, influenza A/B viruses, and respiratory syncytial virus has received the CE mark.

The PKamp Respiratory SARS-CoV-2 RT-PCR Panel is also being reviewed by the US Food and Drug Administration for Emergency Use Authorization, the Waltham, Massachusetts-based company said. The test is designed to save resources by testing for the four viruses in one test using single nasopharyngeal, oropharyngeal, or nasal swab samples, and is for use with PerkinElmer's automated viral nucleic extractor.

In July, the firm's test for antibodies against SARS-CoV-2 using dried blood spots also received the CE mark. Its New Coronavirus Nucleic Acid Detection Kit received EUA in March.